阿尔蒂维昂

US · AORT #3212 按市值排名

21.78 -0.09 -0.41%

实时 - 追踪5344个代码 - 心跳于209秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

增持

机构持股总比例上升了0.2个百分点。

机构持股

机构持股比例: 96.54% +0.24pp
机构数量: 255
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund73.44%

Hedge Fund10.53%

Public Company6.40%

Individual/Insider5.07%

VC/PE Fund3.92%

Private Company1.14%

Government Pension Fund0.82%

Insurance Company0.27%

主要股东截至 2026-06-30

BlackRock 13.69% · 6.67M 股

Macquarie Investment Management Business Trust 6.53% · 3.18M 股

Morgan Stanley 4.78% · 2.33M 股

Vanguard Capital Management, LLC 4.75% · 2.32M 股

Juniper Investment Company, LLC 4.14% · 2.02M 股

FMR 4.03% · 1.96M 股

State Street Global Advisors 3.81% · 1.86M 股

Ophir Asset Management Pty Ltd 3.69% · 1.80M 股

Perceptive Advisors LLC 3.56% · 1.74M 股

Conestoga Capital Advisors, LLC 3.33% · 1.62M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 20次买入 · 28次卖出

姓名	职务	持股比例
James Mackin	Chairperson & CEO	1.80%
John Davis	Senior Vice President of Global Sales & Marketing	0.47%
Lance Berry	Chief Financial Officer	0.43%
Jean Holloway	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary	0.38%
Daniel Bevevino	Independent Director	0.32%
Thomas Ackerman	Independent Director	0.32%
Amy Horton	VP & Chief Accounting Officer	0.29%
Jon Salveson	Independent Director	0.28%
James Bullock	Independent Director	0.16%
Jeffrey Burbank	Independent Director	0.13%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-09	Andrew Green	Senior Vice President of Regulatory & Quality	Open Market Disposition	-11,480	$24.97
2026-09-02	Andrew Green	Senior Vice President of Regulatory & Quality	Open Market Disposition	-8,003	$26.02–27.27
2026-09-02	Andrew Green	Senior Vice President of Regulatory & Quality	Intent to Sell (Form 144)	-1,493	$26.02
2026-09-01	Andrew Green	Senior Vice President of Regulatory & Quality	Intent to Sell (Form 144)	-6,510	$27.27
2026-08-26	Marshall Stanton	Senior VP of Clinical Research & Chief Medical Officer	Intent to Sell (Form 144)	-7,400	$26.85
2026-08-18	James Mackin	Chairperson & CEO	Open Market Disposition	-70,000	$28.96
2026-08-13	Andrew Green	Senior Vice President of Regulatory & Quality	Open Market Disposition	-616	$28.55
2026-08-13	Lance Berry	Chief Financial Officer	Open Market Disposition	-715	$28.55
2026-08-11	Jean Holloway	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary	Open Market Disposition	-977	$28.49
2026-06-10	Andrew Green	Senior Vice President of Regulatory & Quality	Derivative Exercise and Sale	-44,001	$11.03–20.71
2026-06-01	Anthony Semedo	Independent Director	Other Acquisition	+6,325	--
2026-06-01	Anthony Semedo	Independent Director	Other Disposition	-6,325	--
2026-05-31	Andrew Green	Senior Vice President of Regulatory & Quality	Initial Statement of Beneficial	0	--
2026-05-17	James Bullock	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Thomas Ackerman	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Anthony Semedo	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Daniel Bevevino	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Jeffrey Burbank	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Jon Salveson	Independent Director	Other Acquisition	+7,576	--
2026-05-17	Marna Borgstrom	Independent Director	Other Acquisition	+7,576	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。